Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Therapeutic efficacy for MPSVII was evaluated in and ex vivo experiments using these encapsulated genetically engineered GUSB-encoding IHAE cells.
|
16636519 |
2006 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We identified two different exonic point mutations causing beta-glucuronidase (beta G1) deficiency in two Japanese patients with mucopolysaccharidosis type VII (MPSVII).
|
1702266 |
1991 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Four novel mutations in mucopolysaccharidosis type VII including a unique base substitution in exon 10 of the beta-glucuronidase gene that creates a novel 5'-splice site.
|
7633414 |
1995 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
In this novel strategy, the xenotransplanted murine recipients were also GUSB-deficient, allowing a detailed evaluation of therapeutic efficacy in a host with MPSVII.
|
15194052 |
2004 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Transgenic mice homozygous for the mucopolysaccharidosis VII mutation expressed high levels of human beta-glucuronidase activity in all tissues examined and were phenotypically normal.
|
2111021 |
1990 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings.
|
11228259 |
2001 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by deficient β-glucuronidase (β-gluc) activity.
|
30413728 |
2018 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is an inherited disease resulting from deficient activity of the lysosomal acid hydrolase beta-glucuronidase (GUSB) and has been reported in humans, mice, cats, and dogs.
|
9521879 |
1998 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A recombinant adenovirus carrying the human beta-glucuronidase cDNA coding region under the control of a non-tissue-specific promoter was injected intravitreally or subretinally into the eyes of mice with mucopolysaccharidosis VII.
|
7644479 |
1995 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
|
10985954 |
2000 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
MSC-derived exosomes were able to fuse with the lysosomes within corneal cells, enabling delivering of MSC-derived active β-glucuronidase and consequent catabolism of accumulated glycosaminoglycans, indicating their therapeutic potential in the treatment of Mucopolysaccharidosis VII (Sly Syndrome).
|
29774506 |
2019 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
A family of domestic cats was found that exhibited clinical and biochemical abnormalities consistent with mucopolysaccharidosis VII, an autosomal recessive lysosomal storage disorder caused by beta-glucuronidase deficiency. beta-Glucuronidase activity was undetectable in affected cat fibroblasts and restored by retroviral gene transfer of rat beta-glucuronidase cDNA. beta-Glucuronidase mRNA was normal in affected cat testis by Northern blot analysis.
|
10366443 |
1999 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Sly syndrome (Mucopolysaccharidosis Type VII) is an autosomal recessive metabolic storage disorder due to mutations in the GUSB gene encoding the enzyme beta-glucuronidase.
|
27648682 |
2017 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis Type VII (MPS7, also called β-glucuronidase deficiency or Sly syndrome; MIM 253220) is an extremely rare autosomal recessive lysosomal storage disease, caused by mutations in the GUSB gene.
|
30653816 |
2019 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.
|
24343103 |
2014 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is an inherited disease caused by beta-glucuronidase (beta-glu) deficiency.
|
11906211 |
2002 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Low enzymatic activity can be related to a non-pathological 'pseudodeficiency' allele for beta-glucuronidase; this woman appears to be an apparent compound heterozygote for this allele and mucopolysaccharidosis VII.
|
1779649 |
1991 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The low beta-glucuronidase activity in another mild MPS VII patient was due to reduced biosynthesis of stable mRNA from one allele, and a W446X mutation on the second.
|
9490302 |
1998 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
We have used the beta-glucuronidase-deficient mouse model of mucopolysaccharidosis type VII (MPS VII) to develop an alternative approach to therapy.
|
11044913 |
2000 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
We report on a 20-year-old male with a beta-glucuronidase (GUSB) deficiency mucopolysaccharidosis.
|
1456283 |
1992 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A point mutation which occurred in the human beta-glucuronidase gene in a patient with mucopolysaccharidosis type VII was also conserved.
|
1318788 |
1992 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The beta-glucuronidase (GUSB) mutation of the mucopolysaccharidosis type VII (MPSVII) mouse was backcrossed onto the nonobese diabetic/severe combined immunodeficient (NOD/SCID) xenotransplantation strain.
|
12406886 |
2003 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Dogs with mucopolysaccharidosis VII (MPS VII) were injected intravenously at 2-3 days of age with a retroviral vector (RV) expressing canine beta-glucuronidase (cGUSB).
|
12232044 |
2002 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
|
10022533 |
1999 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is caused by the deficiency of the lysosomal hydrolase β-glucuronidase.
|
20864369 |
2010 |